Cargando…

Mechanisms of miR-3189-3p-mediated inhibition of c-MYC translation in triple negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by the lack of estrogen receptor, progesterone receptor, and HER2. Our lab previously characterized miR-3189-3p as a microRNA with potent anti-cancer activity against glioblastoma. Here, we hypot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vittori, Cecilia, Jeansonne, Duane, Yousefi, Hassan, Faia, Celeste, Lin, Zhen, Reiss, Krzysztof, Peruzzi, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158314/ https://www.ncbi.nlm.nih.gov/pubmed/35642054 http://dx.doi.org/10.1186/s12935-022-02620-z

Ejemplares similares

Attenuated Negative Feedback in Monocyte-Derived Macrophages From Persons Living With HIV: A Role for IKAROS
por: Faia, Celeste, et al.
Publicado: (2021)

RF amplitude normalizer (PS/RF-HC 3189)
por: Paoluzzi, M
Publicado: (1996)

RF amplitude normalizer (PS/RF-HC 3189)
por: Paoluzzi, M
Publicado: (1996)

Differential Effects of MicroRNAs on Glioblastoma Growth and Migration
por: Jeansonne, Duane, et al.
Publicado: (2013)

Anti-glioblastoma effects of phenolic variants of benzoylphenoxyacetamide (BPA) with high potential for blood brain barrier penetration
por: Stalinska, Joanna, et al.
Publicado: (2022)

3189 Transmitting wisdom and enhancing KL2 training through the use of exit presentations
por: Lamere, Michelle, et al.
Publicado: (2019)

miR-3189-targeted GLUT3 repression by HDAC2 knockdown inhibits glioblastoma tumorigenesis through regulating glucose metabolism and proliferation
por: Kwak, Sungmin, et al.
Publicado: (2022)

Targeting MYC for triple-negative breast cancer treatment
por: Klauber-DeMore, Nancy, et al.
Publicado: (2018)

Gain-of-Function Polymorphisms in Human Inflammasomes: Implications for Cystic Fibrosis
por: Jeansonne, Duane, et al.
Publicado: (2021)

miR-3189-3p Mimics Enhance the Effects of S100A4 siRNA on the Inhibition of Proliferation and Migration of Gastric Cancer Cells by Targeting CFL2
por: Bian, Yue, et al.
Publicado: (2018)

Translating the role of PARP inhibitors in triple-negative breast cancer
por: Beniey, Michèle, et al.
Publicado: (2019)

Comment on: Lazo et al. NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes. Diabetes 2013;62:3189–3193
por: Moro, Cedric, et al.
Publicado: (2013)

A miRNA Signature for Cognitive Deficits and Alcohol Use Disorder in Persons Living with HIV/AIDS
por: Wyczechowska, Dorota, et al.
Publicado: (2017)

High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer
por: Katsuta, Eriko, et al.
Publicado: (2019)

MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC inhibitor, MYCi975
por: Tang, Minhong, et al.
Publicado: (2022)

MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
por: Horiuchi, Dai, et al.
Publicado: (2012)

Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

Serum microRNAs associated with concussion in football players
por: Wyczechowska, Dorota, et al.
Publicado: (2023)

Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
por: Camarda, Roman, et al.
Publicado: (2016)

MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling
por: Zimmerli, Dario, et al.
Publicado: (2022)

Regulation of emergency granulopoiesis during infection
por: Paudel, Sagar, et al.
Publicado: (2022)

SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer
por: Li, Ming, et al.
Publicado: (2019)

Importance of Copy Number Alterations of FGFR1 and C-MYC Genes in Triple Negative Breast Cancer
por: Nedeljković, Milica, et al.
Publicado: (2019)

High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancer
por: Gupta, Nidhi, et al.
Publicado: (2017)

Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells
por: Yin, Shuping, et al.
Publicado: (2017)

New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription
por: Hu, Ming-Hao, et al.
Publicado: (2019)

PRMT1 Confers Resistance to Olaparib via Modulating MYC Signaling in Triple-Negative Breast Cancer
por: Hsu, Wen-Jing, et al.
Publicado: (2021)

The role of microRNA-4723-5p regulated by c-myc in triple-negative breast cancer
por: Jin, Xi-Xin, et al.
Publicado: (2022)

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer
por: Doha, Zinab O., et al.
Publicado: (2023)

c-Myc steers translation in lymphoma
por: Cargnello, Marie, et al.
Publicado: (2019)

Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers
por: Soung, Young Hwa, et al.
Publicado: (2020)

The Novel Circular RNA Circ-PGAP3 Promotes the Proliferation and Invasion of Triple Negative Breast Cancer by Regulating the miR-330-3p/Myc Axis
por: He, Dabao, et al.
Publicado: (2020)

Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers
por: Wang, Edina, et al.
Publicado: (2018)

Diclofenac impairs the proliferation and glucose metabolism of triple-negative breast cancer cells by targeting the c-Myc pathway
por: Yang, Lihui, et al.
Publicado: (2021)

MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer
por: Wu, Si-Yu, et al.
Publicado: (2021)

Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates
por: Bertoli, Gloria, et al.
Publicado: (2021)

Myc coordinates transcription and translation to enhance transformation and suppress invasiveness
por: Elkon, Ran, et al.
Publicado: (2015)

Myc, Oncogenic Protein Translation, and the Role of Polyamines
por: Flynn, Andrea T., et al.
Publicado: (2018)

Ceritinib is a novel triple negative breast cancer therapeutic agent
por: Dong, Shengli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m30di7equec38jc6dfrs6g5ra0